제품번호 | 종 | 제품 설명 | 구조 | 순도 | 특징 |
---|---|---|---|---|---|
AK1-H5283 | Human | Human Akt1 Protein, His,Strep II Tag | ![]() |
![]() ![]() |
Name | Research Code | Research Phase | Company | Indications | Clinical Trials |
---|---|---|---|---|---|
Uprosertib/Trametinib Dimethyl Sulfoxide | Phase 2 Clinical | Novartis Pharma Ag | Leukemia, Myeloid, Acute; Endometrial Neoplasms; Uterine Cervical Neoplasms | Details | |
Hu-7691 | Hu-7691 | Phase 1 Clinical | Zhejiang University | Neoplasms | Details |
Oxysterols (Intsel Chimos) | Clinical | Centre National De La Recherche Scientifique (Cnrs) | Glioma | Details | |
NTQ-1062 | NTQ1062; NTQ-1062 | Phase 1 Clinical | Nanjing Zhengda Tianqing Pharmaceutical Co Ltd | Solid tumours | Details |
MK-2206 | MK2206; MK-2206; BIND-2206; NSC-749607 | Merck Sharp & Dohme Corp | Details | ||
Uprosertib | GSK-795; GSK-2141795; GSK-2141795C; UPB-795 | Glaxosmithkline Plc, Novartis Pharma Ag, National Cancer Institute | Details | ||
Palomids | P-529; P-52901; RES-529; SG-00529; Palomid-529 | Diffusion Pharmaceuticals | Details | ||
Honokiol | HU-002; JRF-101 | Phase 1 Clinical | Anacor Pharmaceuticals | Carcinoma, Non-Small-Cell Lung | Details |
XL-418 | XL-418; EXEL-9418 | Exelixis | Details | ||
MSC-2363318A | M-2698; MSC-2363318A | Merck Serono | Details | ||
Iopofosine I-131 | HOT; CLR1404 I-131; I-131-CLR1404; (131)I-NM 404; 131I-NM-404; CLR-131; (131)I-CLR1404; NM404 | University Of Michigan | Details | ||
BAY-1125976 | BAY-1125976 | Bayer AG | Details | ||
Selumetinib sulfate/MK-2206 | Phase 2 Clinical | Astrazeneca Plc, Merck & Co Inc | Triple Negative Breast Neoplasms; Precursor Cell Lymphoblastic Leukemia-Lymphoma | Details | |
Ipatasertib Dihydrochloride | RG-7440; GCD-0068; GDC-0068; RO-5532961 | Phase 3 Clinical | Array Biopharma, F. Hoffmann-La Roche Ltd | Ovarian Neoplasms; Solid tumours; Neoplasm, Residual; Stomach Neoplasms; Triple Negative Breast Neoplasms; Neoplasms; Glioblastoma; Prostatic Neoplasms, Castration-Resistant; Breast Neoplasms; Prostatic Neoplasms; Hepatic Insufficiency; Endometrial Neoplasms; Neoplasms, Unknown Primary; Neoplasm Metastasis; Carcinoma, Non-Small-Cell Lung | Details |
TAS-117 | TAS-117 | Phase 2 Clinical | Otsuka Pharmaceutical Co Ltd, Taiho Pharmaceutical Co Ltd | Solid tumours | Details |
Miransertib | MK-7075; ARQ-092 | Phase 2 Clinical | Arqule Inc | Proteus Infections | Details |
Triciribine Phosphate | NSC-154020; PTX-002; API-2; TCN-P; VQD-002-ORAL; VQD-002; NSC-280594; PTX-200 | Phase 2 Clinical | National Cancer Institute | Ovarian Neoplasms; Hematologic Neoplasms; Leukemia; Neoplasms; Breast Neoplasms | Details |
HZB-0071 | HZB-0071 | Phase 1 Clinical | Wuxi Apptec Co Ltd, Heilongjiang Zbd Pharmaceutical Co Ltd | Neoplasms | Details |
TIC-10 | ONC201 - Oncoceutics; ONC201/TIC10; NSC-350625; TIC-10; ONC-201 | Phase 3 Clinical | Oncoceutics | Solid tumours; Glioblastoma; Triple Negative Breast Neoplasms; Myelodysplastic Syndromes; Thalamic Diseases; Multiple Myeloma; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Gliosarcoma; Colorectal Neoplasms; Diffuse Intrinsic Pontine Glioma; Leukemia, Myeloid, Acute; Endometrial Neoplasms; Glioma; Carcinoma, Non-Small-Cell Lung | Details |
RX-0301 | RX-0201 nanoliposomal; RX-0201 Nano; RX-0201-N; RX-0301; WGI-0301; RX-0201 | Phase 1 Clinical | Rexahn Pharmaceuticals | Solid tumours; Liver Neoplasms; Carcinoma, Renal Cell; Neoplasms; Pancreatic Neoplasms | Details |
Capivasertib | AZD-5363 | Phase 3 Clinical | Astrazeneca Pharmaceutical Co Ltd | Solid tumours; Ovarian Neoplasms; Hematologic Neoplasms; Neoplasms; Triple Negative Breast Neoplasms; Prostatic Neoplasms, Castration-Resistant; Breast Neoplasms; Prostatic Neoplasms; Lymphoma, Non-Hodgkin; Metastatic breast cancer; Carcinoma, Squamous Cell; Endometrial Neoplasms; Adenocarcinoma; Carcinoma, Non-Small-Cell Lung; Uterine Cervical Neoplasms | Details |
Afuresertib | ASB-183; GSK-2110183; GSK-2110183B; GSK-2110183C; GSK-21110183; LAE-002 | Phase 3 Clinical | Glaxosmithkline Plc, Novartis Pharma Ag | Histiocytosis, Langerhans-Cell; Uterine Cervical Neoplasms; Carcinoma, Non-Small-Cell Lung; Adenocarcinoma; Leukemia, Lymphocytic, Chronic, B-Cell; Endometrial Neoplasms; Metastatic breast cancer; Fallopian Tube Neoplasms; Peritoneal Neoplasms; Prostatic Neoplasms; Ovarian Neoplasms; Breast Neoplasms; Multiple Myeloma; Neoplasms; Triple Negative Breast Neoplasms; Stomach Neoplasms; Esophageal Neoplasms; Solid tumours; Hematologic Neoplasms | Details |
This web search service is supported by Google Inc.